Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Pharma Mar isolates new cytotoxic agents from marine sponge

May 6, 1997

OXiGENE initiates U.S. preclinical and clinical research

May 2, 1997

Targeted Genetics' E1A tumor suppressor gene product progresses in clinical trials

May 2, 1997

Natural compounds that inhibit oncogene function from Terumo

May 2, 1997

Schering-Plough develops potent farnesyltransferase inhibitor

April 30, 1997

NCI identifies compounds effective against aggressive human tumors

April 30, 1997

Potent antitumor farnesyltransferase inhibitors discovered by Parke-Davis

April 29, 1997

PD-170262: potent and selective PDGF TK inhibitor from Parke-Davis

April 29, 1997

Radiosensitizing taxanes prepared by Florida State University

April 29, 1997

Agents for hyperandrogenic disorders from Merck & Co.

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026